Back to News
Market Impact: 0.2
Here's Why Allarity Therapeutics, Inc. (ALLR) Is a Great 'Buy the Bottom' Stock Now
Source: zacks.com
Market Technicals & FlowsAnalyst EstimatesHealthcare & Biotech
Allarity Therapeutics (ALLR) has formed a hammer chart pattern after recent losses, which the article says indicates support. Upward earnings-estimate revisions could contribute to a near-term trend reversal, though no price target or specific revision figures are provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
ALLR0.35
More News
- Verizon stock heads for worst day since 2002 as SpaceX U.S. network plans whack telcos
- French yields are near levels not seen since 2002. Why that could give U.S. Treasurys a boost
- SpaceX’s Wireless Threat Rises With Spectrum Deal
- What's behind the recovery rally in tech stocks — plus, Elon Musk's very good week
- Pilot killed in attacks by Iran-backed Houthis on Riyadh airport; Saudi-led coalition vows 'firm' response
- OpenAI's revenue scare, Delta earnings, what investors think of a Starbucks-Chipotle deal and more in Morning Squawk